Tandem Diabetes Care Inc (TNDM)
30.81
+0.07
(+0.23%)
USD |
NASDAQ |
Nov 22, 16:00
30.90
+0.09
(+0.29%)
After-Hours: 20:00
Tandem Diabetes Care Cash from Financing (Quarterly): -4.519M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.519M |
| June 30, 2024 | -3.002M |
| March 31, 2024 | 13.59M |
| December 31, 2023 | 2.617M |
| September 30, 2023 | -1.911M |
| June 30, 2023 | 3.948M |
| March 31, 2023 | -0.541M |
| December 31, 2022 | 6.10M |
| September 30, 2022 | -0.774M |
| June 30, 2022 | 8.051M |
| March 31, 2022 | 3.50M |
| December 31, 2021 | 15.89M |
| September 30, 2021 | 18.85M |
| June 30, 2021 | 13.62M |
| March 31, 2021 | 3.573M |
| December 31, 2020 | 9.204M |
| September 30, 2020 | 29.93M |
| June 30, 2020 | 263.82M |
| March 31, 2020 | 11.48M |
| December 31, 2019 | 6.418M |
| September 30, 2019 | 7.034M |
| June 30, 2019 | 8.793M |
| March 31, 2019 | 1.962M |
| December 31, 2018 | 1.957M |
| Date | Value |
|---|---|
| September 30, 2018 | 22.05M |
| June 30, 2018 | 22.51M |
| March 31, 2018 | 70.67M |
| December 31, 2017 | 14.68M |
| September 30, 2017 | 3.99M |
| June 30, 2017 | -0.156M |
| March 31, 2017 | 21.86M |
| December 31, 2016 | 35.73M |
| September 30, 2016 | 0.032M |
| June 30, 2016 | 1.451M |
| March 31, 2016 | 15.10M |
| December 31, 2015 | 1.269M |
| September 30, 2015 | 0.093M |
| June 30, 2015 | 1.825M |
| March 31, 2015 | 65.07M |
| December 31, 2014 | 1.646M |
| September 30, 2014 | 0.078M |
| June 30, 2014 | 1.888M |
| March 31, 2014 | 0.027M |
| December 31, 2013 | 128.24M |
| September 30, 2013 | -1.014M |
| June 30, 2013 | 16.38M |
| March 31, 2013 | 22.49M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-4.519M
Minimum
Sep 2024
263.82M
Maximum
Jun 2020
19.99M
Average
6.259M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Masimo Corp | -1.60M |
| RxSight Inc | 0.878M |
| Perspective Therapeutics Inc | 0.628M |
| Xtant Medical Holdings Inc | 5.314M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 26.78M |
| Cash from Investing (Quarterly) | -19.90M |
| Free Cash Flow | -37.35M |
| Free Cash Flow Per Share (Quarterly) | 0.3287 |
| Free Cash Flow to Equity (Quarterly) | 21.04M |
| Free Cash Flow to Firm (Quarterly) | 21.54M |
| Free Cash Flow Yield | -1.86% |